Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | CREBBP | Q92793 | 2/20 | 0.45 |
| ▸ | EP300 | Q09472 | 1/20 | 0.44 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.44 |
| ▸ | SELE | P16581 | 1/20 | 0.44 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.37 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.37 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | MGLL | Q99685 | 1/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4322060 | 0.86 | MEN1 (0.50) | MEN1KMT2ACREBBPEP300ICAM1 | |
| SCHEMBL3811958 | 0.82 | KMT2A (0.64) | MEN1KMT2ACREBBPEP300ICAM1 | |
| SCHEMBL4505041 | 0.82 | MEN1 (0.54) | MEN1KMT2ACREBBPEP300 | |
| SCHEMBL4680154 | 0.81 | ICAM1 (0.39) | MEN1KMT2ACREBBPEP300ICAM1 | |
| SCHEMBL4309447 | 0.80 | CREBBP (0.59) | MEN1KMT2ACREBBPEP300ICAM1 | |
| SCHEMBL22165283 | 0.78 | ICAM1 (0.39) | MEN1KMT2ACREBBPEP300ICAM1 | |
| SCHEMBL23647809 | 0.78 | ICAM1 (0.39) | MEN1KMT2ACREBBPEP300ICAM1 | |
| SCHEMBL7975649 | 0.78 | MEN1 (0.44) | MEN1KMT2ACREBBPEP300ICAM1 | |
| SCHEMBL22334887 | 0.78 | MEN1 (0.47) | MEN1KMT2ACREBBPICAM1SELE | |
| SCHEMBL4311192 | 0.78 | CREBBP (0.44) | MEN1KMT2ACREBBPEP300ICAM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1362856-B1 | WATER-SOLUBLE TRIAZOLE FUNGICIDE | DAIICHI SANKYO CO LTD (JP) | 2008-09-10 | — | — | EP | disclosed |
| US-7230023-B2 | Water-soluble triazole fungicide | SANKYO COMPANY, LIMITED (JP) | 2007-06-12 | — | — | US | disclosed |
| US-20040198790-A1 | Water-soluble triazole fungicide | SANKYO COMPANY, LIMITED (JP) | 2004-10-07 | — | — | US | disclosed |
| EP-1362856-A1 | WATER-SOLUBLE TRIAZOLE FUNGICIDE | Sankyo Company, Limited (JP) | 2003-11-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040198790-A1 | Water-soluble triazole fungicide | ERG28, CYP51A1, XDH | MEN1 2081/4885KMT2A 2939/4885CREBBP 4868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.